Rock Creek Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rock Creek Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,205	Closed	-$1.49M	–	237
2021 Q4	$1.49M	Buy	+16,205	New	+$1.07M	0.22%	47

Rock Creek Group's ARNA Position: Q1 2022 in Review

Rock Creek Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 16,205 shares — an estimated $1.49M sold.

Rock Creek Group first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.49M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Rock Creek Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Rock Creek Group sold 16,205 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.49M.
Rock Creek Group first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Rock Creek Group's Arena Pharmaceuticals Inc position peaked at $1.49M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.